Sign In to Follow Application
View All Documents & Correspondence
View All Documents & Correspondence
Pharmaceutical Composition Of A Cyp11 A1 Inhibitor
Abstract: The present invention relates to a pharmaceutical composition for oral administration, particularly in the form of a tablet or a powder suitable to be filled into a capsule shell, comprising 2-(isoindolin-2-ylmethyl)-5-((1-(methylsulfonyl)-piperidin-4-yl)methoxy)-4H-pyran-4-one (I) or a pharmaceutically acceptable salt thereof as an active ingredient. Compound (I) or a pharmaceutically acceptable salt thereof is a selective inhibitor of CYP11A1 enzyme and is useful in the treatment of hormonally regulated diseases such as cancer including prostate cancer and breast cancer.
Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence
Notices, Deadlines & Correspondence
Patent Information
Application #
Filing Date
09 July 2024
Publication Number
51/2024
Publication Type
INA
Invention Field
CHEMICAL
Status
Email
Parent Application
Applicants
ORION CORPORATION
Orionintie 1
02200 Espoo
Inventors
1. SALMIA, Jukka
Forsellesintie 18 A 3
02700 Kauniainen
2. SINGHAL, Mayank
2 Cornfield Close
MacClesfield SK10 2TY
3. TURUNEN, Elina
c/o Orion Corporation
P.O.Box 65
02101 Espoo
Specification
Documents
Application Documents
| # | Name | Date |
|---|---|---|
| 1 | 202417052580-STATEMENT OF UNDERTAKING (FORM 3) [09-07-2024(online)].pdf | 2024-07-09 |
| 2 | 202417052580-REQUEST FOR EXAMINATION (FORM-18) [09-07-2024(online)].pdf | 2024-07-09 |
| 3 | 202417052580-NOTIFICATION OF INT. APPLN. NO. & FILING DATE (PCT-RO-105-PCT Pamphlet) [09-07-2024(online)].pdf | 2024-07-09 |
| 4 | 202417052580-FORM 18 [09-07-2024(online)].pdf | 2024-07-09 |
| 5 | 202417052580-FORM 1 [09-07-2024(online)].pdf | 2024-07-09 |
| 6 | 202417052580-DECLARATION OF INVENTORSHIP (FORM 5) [09-07-2024(online)].pdf | 2024-07-09 |
| 7 | 202417052580-COMPLETE SPECIFICATION [09-07-2024(online)].pdf | 2024-07-09 |
| 8 | 202417052580-Proof of Right [18-07-2024(online)].pdf | 2024-07-18 |
| 9 | 202417052580-FORM-26 [23-08-2024(online)].pdf | 2024-08-23 |
| 10 | 202417052580-FORM 3 [02-01-2025(online)].pdf | 2025-01-02 |
| 11 | 202417052580-MARKED COPIES OF AMENDEMENTS [24-10-2025(online)].pdf | 2025-10-24 |
| 12 | 202417052580-FORM 13 [24-10-2025(online)].pdf | 2025-10-24 |
| 13 | 202417052580-AMMENDED DOCUMENTS [24-10-2025(online)].pdf | 2025-10-24 |